Navigation Links
Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer

the Bcl-2 family of proteins interact with one another, leading researchers to develop a novel compound that causes cancer cells to self-destruct.

ABT-263 recently entered Phase I clinical trials for lymphomas and solid tumors, including small cell lung cancer. Preclinical data has shown that Abbott's Bcl-2 family protein inhibitors bind to Bcl-2 proteins, restoring cell death to cancerous cells. Additionally, the compounds were found to enhance the effects of chemotherapy and radiation used to treat other types of cancer, such as non-small cell lung cancer.

PARP Inhibitors (ABT-888)

DNA damaging agents remain some of the most successful treatments for cancer. The enzyme Poly(ADP-ribose)polymerase (abbreviated PARP) can help repair DNA damage caused by these agents used to treat cancer and render them ineffective. As PARP activity is often increased in cancer cells, it provides these cells with a survival mechanism.

ABT-888 is an oral PARP-inhibitor developed by Abbott researchers to prevent DNA repair in cancer cells and increase the effectiveness of common cancer therapies such as radiation and alkylating agents.

ABT-888 has entered a Phase 0 trial for patients with refractory solid tumors and lymphoid malignancies, and will enter Phase I trials for melanoma this year. Preclinical data indicates ABT-888 has improved the effectiveness of radiation and many types of chemotherapy in animal models of cancer.

Kinase Inhibitors (ABT-869)

Many oncology researchers are currently developing agents that target kinases, a class of enzymes that are often overly activated in cancer cells. Inhibition of the appropriate kinases can suppress tumor growth by cutting off its blood supply.

Discovered by Abbott scientists, ABT-869 is a multitargeted kinase inhibitor that is in Phase I clinical trials for solid tumors and selected hematologic malignancies such as leukemia. Phase II trials for several tumor types will also begin t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. NIEHS Researchers Identify Enzyme Critical in DNA Replication
11. Stanford Researchers Find Brain Pathway of Depression in Rats
Post Your Comments:
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/h699d6/global_healthcare ... Healthcare Cloud Computing Market 2015-2019" report to their ... Cloud Computing market to grow at a CAGR of ... adoption of IT in healthcare has led to a ... Global Healthcare industry. Though there are significant challenges such ...
(Date:3/30/2015)... -- The future of cancer care with radiation oncology ... more precise methods for delivering stereotactic radiosurgery; and ... 150 researchers from leading clinics around the world ... on research funded by Varian Medical Systems (NYSE: ... developing, testing, and validating new innovations, concepts, and ...
(Date:3/30/2015)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ), ... innovative therapeutics primarily in the areas of dermatology ... reported its financial results for the fourth quarter ... a business update. Logo - ... has seen a steady growth and evolution for ...
Breaking Medicine Technology:Global Healthcare Cloud Computing Market 2015-2019 with Agfa, CareCloud, Carestream Health, Cisco, ClearData Networks, Dell, GE & Merge Healthcare Dominating 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 4Radiation Oncology Researchers Glimpse the Future of Cancer Care 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 2RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 4RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 5RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 7RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 8RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 9RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 10
... YORK, May 12, 2011 Reportlinker.com ... report is available in its catalogue: ... 2011 – Socio-Demographic and Economic Overview ... the economic downturn continue to shape ...
... China New Borun Corporation (NYSE: BORN ; ... of corn-based edible alcohol in China, today announced unaudited ... Mr. Jinmiao Wang, Chairman and Chief Executive Officer ... with you another quarter of strong financial performance.  We ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising Healthcare Costs Coupled with the Economic Downturn Continue to Shape the Healthcare Landscape 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising Healthcare Costs Coupled with the Economic Downturn Continue to Shape the Healthcare Landscape 3China New Borun Announces First Quarter 2011 Financial Results 2China New Borun Announces First Quarter 2011 Financial Results 3China New Borun Announces First Quarter 2011 Financial Results 4China New Borun Announces First Quarter 2011 Financial Results 5China New Borun Announces First Quarter 2011 Financial Results 6China New Borun Announces First Quarter 2011 Financial Results 7China New Borun Announces First Quarter 2011 Financial Results 8
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... In a recent report published by SF ... championing effective drug and alcohol treatment for victims suffering ... funds to stabilize the addiction treatment programs, and continue ... and alcohol addiction. Harbor Village Detox is extending its ... disorders in New Jersey, in hopes to help circumvent ...
(Date:3/30/2015)... UT (PRWEB) March 30, 2015 On March ... Business Owners Day. In honor of all small business owners, ... will be spotlighting them. , According to Zane Benefits' ... of our economy, creating 75% of all jobs and employing ... America account for 54% of all U.S. sales. The small ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Follow ... government efforts to develop and establish chronic pain rehabilitation ... Growth in the market is poised to benefit from ... result of the increase in chronic health conditions such ... rheumatoid arthritis, among others. While conventional treatment for pain ...
(Date:3/30/2015)... March 30, 2015 Tel-Aviv – March ... prescription eyewear, announced the closing of $12.5 million in ... of the Viola Group. The funding will further GlassesUSA's ... leading player in the growing global market of online ... in 2009 by CEO Daniel Rothman, COO Eldad Rothman, ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... Expert sorts myth from fact when it comes to toeing ... (HealthDay News) -- Summer is here, and many of you ... beach or in the park. But is that a good ... about your feet, Dr. Tracey Vlahovic, associate professor of podiatric ...
... 20 The United States,has provided $50,000 in ... to assist people affected by the food,shortages in ... emerged in recent months because the flowering of ... rat infestations in,crop-growing areas. With funds provided by ...
... Colo., June 20 Mesa Laboratories,Inc. (Nasdaq: ... performance data,loggers now with real-time capability, the new ... collect data from a process: wired,logging systems or ... of,both worlds and the reliability of over 25 ...
... More Public and Private Investment to Fight,Leading Cause of ... announced,today the launch of a major new initiative to ... Transmitted through mosquitoes, malaria is the fourth leading cause ... world and is a top,killer of children in sub-Saharan ...
... June 20 TeamHealth announced today,that Heidi S. Allen ... reporting directly to the CEO. Ms. Allen is assuming ... on July 31,2008, after nine years with TeamHealth., ... member of TeamHealth,s senior,management team, working with all departments ...
... PICK: Smoking out the mediators of airway damage caused ... pollution and cigarette smoke damage airways has been provided ... Florence, Italy, who studied the effects of such chemicals ... commentary, by Sidney Simon and Wolfgang Liedtke, at Duke ...
Cached Medicine News:Health News:Get in Step With Summer Foot Care 2Health News:Get in Step With Summer Foot Care 3Health News:The DataTrace(R) RF System, the Latest High Performance Radio Data Logger for Real-Time, Process Data Collection, Reporting, and Analysis Is Launched 2Health News:World Vision Launches Initiative to Combat Malaria 2Health News:World Vision Launches Initiative to Combat Malaria 3Health News:TeamHealth Announces Appointment of Heidi Allen as Senior Vice President and General Counsel 2Health News:JCI table of contents: June 20, 2008 2Health News:JCI table of contents: June 20, 2008 3Health News:JCI table of contents: June 20, 2008 4Health News:JCI table of contents: June 20, 2008 5Health News:JCI table of contents: June 20, 2008 6Health News:JCI table of contents: June 20, 2008 7Health News:JCI table of contents: June 20, 2008 8Health News:JCI table of contents: June 20, 2008 9
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
Plastic Economical Single use. Non-Sterile....
Medicine Products: